Remote Collection of Patient Reported Toxicity Using SMS Text Messaging (CareSignal)

Completed

Conditions studied: Cancer

In brief

CareSignal has developed an application that allows for remote collection of patient-reported data such as symptoms or outcomes on any device compatible with the short message service (SMS), otherwise known as "text messaging". The software can be configured to complete symptom monitoring by surveying patients about toxicity using the PRO-CTCAE tools. PRO-CTCAE is the patient reported outcomes version of the CTCAE that was designed by the National Cancer Institute (NCI) for use in clinical trials.

Key facts

Study ID

NCT04437472

Run by

Washington University School of Medicine

People needed

30

Starts

2020-09-22

Expected to finish

2021-07-09

Last updated by the study team

2021-08-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Currently planning to receive radiotherapy for 2 or more fractions with or without chemotherapy.
• Ability to understand and willingness to sign an IRB approved written informed consent document (or that of legally authorized representative, if applicable).
• Age 18 years or older.

You may not qualify if…

• Unable to reliably access and use a device compatible with CareSignal software.

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.